INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$5.1M

$5,074,529

View Raw Line-Items
Live Feed: 2026-03-11
RAPP S
Rapport Therapeutics, Inc.
Gault Cheryl • COO
Discretionary Sell
2026-03-05 $58,265
RAPP S
Rapport Therapeutics, Inc.
Ceesay Abraham • CEO
10b5-1 Sell
2026-02-18 $320,373x4
RAPP S
Rapport Therapeutics, Inc.
Bredt David • Officer • Chief Scientific Officer
10b5-1 Sell
2026-02-17 $246,655x3
RAPP S
Rapport Therapeutics, Inc.
Ceesay Abraham • CEO
10b5-1 Sell
2026-01-20 $285,071x2
RAPP S
Rapport Therapeutics, Inc.
Bredt David • Officer • Chief Scientific Officer
10b5-1 Sell
2026-01-15 $228,132x2
RAPP S
Rapport Therapeutics, Inc.
Ceesay Abraham • CEO
10b5-1 Sell
2025-12-17 $323,508x6
RAPP S
Rapport Therapeutics, Inc.
Bredt David • Officer • Chief Scientific Officer
10b5-1 Sell
2025-12-15 $255,130x2
RAPP S
Rapport Therapeutics, Inc.
Gault Cheryl • COO
10b5-1 Sell
2025-11-26 $150,486
RAPP S
Rapport Therapeutics, Inc.
Bredt David • Officer • Chief Scientific Officer
10b5-1 Sell
2025-11-17 $214,091x2
RAPP S
Rapport Therapeutics, Inc.
Ceesay Abraham • CEO
10b5-1 Sell
2025-11-17 $275,047x4
RAPP S
Rapport Therapeutics, Inc.
Bredt David • Officer • Chief Scientific Officer
10b5-1 Sell
2025-10-15 $219,196x2
RAPP S
Rapport Therapeutics, Inc.
Ceesay Abraham • CEO
10b5-1 Sell
2025-10-15 $281,729x4
RAPP S
Rapport Therapeutics, Inc.
Ceesay Abraham • CEO
10b5-1 Sell
2025-09-17 $2,011,197Largex4
RAPP S
Rapport Therapeutics, Inc.
Bredt David • Officer • Chief Scientific Officer
10b5-1 Sell
2025-09-15 $205,649x2